Patent · US Expired

Inhibitors of Akt activity

US7579355B2 · kind B2 · utility

6Cited by
8References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2004
Grant dateAug 25, 2009
Priority date
Expiry dateNov 11, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds which contain a substituted pyridine moeity which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.